Based on the key findings of the current study, we conclude that GSK3β can promote degradation of HDAC4, which lead to an overall downregulation of the downstream KLF5/ASK1 axis, thereby alleviating the development of IDD. The gene discussed is MAP3K5; the disease is intervertebral disk degenerative disorder.